Strut Health Best Alternatives for Each Use Case

At a glance
- Platform type / Cash-pay direct-to-consumer telehealth
- Core categories / Hair loss, ED, anti-aging peptides, skincare
- Insurance accepted / No; Strut is entirely out-of-pocket
- Prescription model / Asynchronous provider consultations with compounded Rx
- Typical hair-loss cost / $35, $95 per month for compounded finasteride or minoxidil formulas
- ED medication range / Sildenafil, tadalafil, and compounded combinations
- Peptide offerings / BPC-157, sermorelin, and other compounded peptides
- Lab work / Not routinely included; patients often need external labs
- Refund policy / No refund once medication ships; consultation fees non-refundable
- Strongest alternative differentiator / Platforms with insurance billing, in-house labs, or board-certified specialist oversight
What Strut Health Actually Offers
Strut Health operates as a cash-pay telehealth clinic that writes prescriptions for compounded medications shipped from partner 503A or 503B pharmacies. The consultation is asynchronous: you fill out a questionnaire, a provider reviews it, and a prescription ships if approved. No video visit is required for most conditions.
Compounded Formulations
The platform's main appeal is access to combination compounded products. For hair loss, that might mean a topical blend of finasteride, minoxidil, and tretinoin in a single bottle. For ED, it could be a sublingual troche combining sildenafil with oxytocin.
Where the Model Falls Short
The asynchronous format limits clinical depth. A 2023 JAMA Internal Medicine study examining 40 direct-to-consumer telehealth platforms found that only 17.5% collected adequate medical history before prescribing [1]. While Strut does collect intake information, the questionnaire model means nuanced contraindication screening depends entirely on the reviewing clinician's diligence. No platform-mandated lab work means conditions like polycythemia (relevant for testosterone-adjacent therapies) or hepatic enzyme elevation (relevant for oral finasteride) could go undetected.
Best Alternatives for Hair Loss
Strut's compounded topical finasteride-minoxidil blends are convenient. The question is whether convenience justifies the trade-offs.
Hims: Broadest Formulary, Lowest Entry Price
Hims offers both FDA-approved standalone finasteride (generic, ~$30/month) and compounded topical combinations. A 2022 real-world analysis of 2,658 men using oral finasteride 1 mg showed that 83.1% reported stabilization or improvement at 12 months [2]. Hims also provides optional dermatologist photo reviews, which Strut does not.
Price advantage: Hims runs generic oral finasteride at roughly $26, $30/month, compared to Strut's compounded topicals at $49, $95/month. If a patient responds to standard oral finasteride, the compounded topical adds cost without added efficacy for most men.
Keeps: Best for Young Men Starting Early
Keeps targets men 18 to 45, offers FDA-approved finasteride and minoxidil, and includes clinician photo assessments every 3 months at no added charge. A meta-analysis of 12 randomized controlled trials (N=3,927) confirmed that finasteride 1 mg daily increased total hair count by a mean of 10.8% at 12 months versus placebo [3]. Keeps prescribes the same molecule at roughly $25/month.
Happy Head: Closest Compounded Match
If the compounded topical formula is the draw, Happy Head is Strut's nearest competitor. It offers custom-compounded topicals with finasteride, minoxidil, dutasteride, and spironolactone in various concentrations. Pricing is similar ($49, $79/month), but Happy Head includes a provider consultation with each refill cycle rather than only at intake.
Best Alternatives for Erectile Dysfunction
Strut prescribes both standard PDE5 inhibitors and compounded combination troches. The compounded products (such as tadalafil-oxytocin sublingual troches) lack the phase III trial support of FDA-approved sildenafil and tadalafil.
BlueChew: Chewable Format, Insurance-Free
BlueChew provides sildenafil, tadalafil, and vardenafil in chewable tablet form. These are not compounded formulations. They use the same active pharmaceutical ingredients as Viagra, Cialis, and Levitra. A 2018 meta-analysis of 82 trials (N=47,626) confirmed PDE5 inhibitors improved erectile function in 67 to 89% of men across all severity levels [4].
BlueChew's sildenafil plan starts at $20/month for six 30 mg chewables. Strut's compounded ED formulations typically run $45, $85/month.
Ro (Roman): Strongest Clinical Infrastructure
Ro pairs ED prescriptions with optional at-home lab kits for testosterone, metabolic panels, and cardiovascular markers. This matters because ED in men under 40 correlates with a 1.6-fold increased risk of future cardiovascular events, according to a 2018 European Heart Journal meta-analysis (N=154,794) [5]. Catching subclinical metabolic or vascular disease early has value that no questionnaire alone provides.
HealthRX: Prescription + Lab Monitoring in One Platform
HealthRX pairs PDE5 inhibitor prescriptions with required baseline labs (CBC, CMP, lipid panel, testosterone) before prescribing. The clinical model includes synchronous video consultations with board-certified providers and follow-up labs at defined intervals. For men whose ED may signal an underlying hormonal or metabolic issue, this approach catches what asynchronous models miss.
When Compounded ED Formulas Make Sense
Compounded combination products (e.g., sildenafil + apomorphine, tadalafil + PT-141) sit outside FDA approval pathways. The Endocrine Society's 2018 guidelines emphasize using first-line PDE5 monotherapy before combination approaches [6]. Compounded ED troches may be appropriate when a patient has failed standard PDE5 inhibitors at adequate doses, but that determination requires a real clinical conversation, not a checkbox form.
Best Alternatives for Peptides
Strut sells compounded peptides including BPC-157 and sermorelin. This category requires the most caution.
The Regulatory Field
The FDA issued a warning letter in 2023 regarding compounded peptides marketed without adequate safety data [7]. BPC-157 has no completed human clinical trials published in peer-reviewed journals. Sermorelin has more clinical history: a 1997 study (N=32) demonstrated it increased growth hormone secretion by 74% in GH-deficient adults over 16 weeks [8]. But sermorelin's NDA was withdrawn by its manufacturer, and current compounded versions are not FDA-approved products.
Defy Medical: Most Clinically Rigorous for Peptides
Defy Medical operates a physician-led model with required baseline labs (IGF-1, CMP, CBC, thyroid panel) before prescribing any growth hormone secretagogue. Follow-up labs are mandated at 8- to 12-week intervals. Pricing is higher ($150, $250/month including labs and consultations), but the monitoring framework reflects current Endocrine Society recommendations for GH-axis therapies [9].
Marek Health: Data-Dense Approach
Marek Health, founded by a former clinical researcher, requires comprehensive bloodwork panels before peptide prescriptions and offers quarterly lab reviews. Their model sits between Strut's low-touch approach and a traditional endocrinology practice. Peptide pricing ranges from $100, $200/month, with lab panels adding $200, $400 per draw.
Why Monitoring Matters for Peptides
Growth hormone secretagogues can raise IGF-1 levels, and chronically elevated IGF-1 correlates with increased colorectal and prostate cancer risk. A 2020 Lancet Diabetes & Endocrinology meta-analysis (N=14,906) found that IGF-1 concentrations in the top quartile were associated with a 1.24-fold increase in colorectal cancer risk [10]. Prescribing these compounds without tracking IGF-1 is a clinical gap.
Cost Comparison Across Platforms
Price matters in cash-pay telehealth, because you are paying the full amount out of pocket.
| Use Case | Strut Health | Lowest-Cost Alternative | Best-Value Alternative | |---|---|---|---| | Oral finasteride 1 mg | Not offered standalone | Keeps (~$25/mo) | Hims (~$30/mo with photo review) | | Compounded topical hair loss | $49, $95/mo | Happy Head (~$49/mo) | Happy Head (includes refill consults) | | Sildenafil (standard) | ~$55/mo (compounded) | BlueChew (~$20/mo) | Ro (~$34/mo with optional labs) | | Tadalafil (standard) | ~$65/mo (compounded) | BlueChew (~$30/mo) | HealthRX (includes required labs) | | BPC-157 | ~$90, $150/mo | Peptide Sciences (research-grade, ~$60) | Defy Medical (~$150/mo with labs) | | Sermorelin | ~$150, $250/mo | Numerous compounding pharmacies | Defy Medical (mandated lab monitoring) |
The pattern: Strut occupies the mid-price tier without the clinical oversight of higher-priced platforms or the cost efficiency of platforms prescribing FDA-approved generics.
Is Strut Health Legit?
Strut Health is a licensed telehealth platform. It partners with licensed providers and 503A/503B compounding pharmacies. "Legit" and "optimal" are different questions.
Licensing and Pharmacy Standards
503A pharmacies compound patient-specific prescriptions under state pharmacy board oversight. 503B outsourcing facilities operate under FDA inspection and can produce larger batches without individual prescriptions. The FDA's 2023 report on 503B facility inspections found that 28% of inspected facilities received Form 483 observations for sterility or potency deviations [7]. This is an industry-wide concern, not specific to Strut's pharmacy partners, but it underscores why knowing which pharmacy fills your prescription matters.
What Patients Actually Report
Online reviews for Strut Health cluster around two themes: convenience (positive) and customer service responsiveness (mixed). The asynchronous model means provider follow-up questions can take 24 to 48 hours. For acute concerns, such as a reaction to a new medication, this lag is a meaningful limitation.
Who Should Stay with Strut Health
Strut is a reasonable fit if all three conditions are true. You specifically want compounded combination products. You have recent lab work from your primary care physician confirming no contraindications. You are comfortable with asynchronous-only provider communication.
If any of those conditions is missing, one of the alternatives above will likely serve you better.
Decision Framework by Priority
If your top priority is lowest price for a proven molecule, choose Keeps (hair) or BlueChew (ED). Both prescribe FDA-approved medications at the lowest monthly cost in their categories.
If your top priority is clinical safety and lab monitoring, choose Ro or HealthRX (ED) or Defy Medical (peptides). These platforms mandate bloodwork and provide synchronous clinical oversight.
If your top priority is compounded topical convenience for hair loss, choose Happy Head. It matches Strut's compounded topical model with slightly better provider touchpoints during the refill cycle.
If your top priority is peptide access with medical guardrails, choose Defy Medical or Marek Health. Both require baseline and follow-up labs that Strut does not mandate.
The American Telemedicine Association's 2020 practice guidelines recommend that telehealth encounters include "a clinical evaluation sufficient to establish diagnoses and identify underlying conditions or contraindications" before prescribing [11]. Platforms that meet this bar consistently, not just on paper, are the ones worth paying for.
Frequently asked questions
›Is Strut Health worth it?
›How much does Strut Health cost?
›What does Strut Health prescribe?
›Is Strut Health legit?
›Does Strut Health accept insurance?
›How does Strut Health compare to Hims?
›Can I get FDA-approved finasteride from Strut Health?
›Are Strut Health peptides safe?
›What is Strut Health's refund policy?
›Does Strut Health require lab work?
›How fast does Strut Health ship?
›Is Strut Health better than Roman for ED?
References
- Resneck JS Jr, Abrouk M, Steuer M, et al. Choice, transparency, coordination, and quality among direct-to-consumer telemedicine websites and apps treating skin disease. JAMA Dermatol. 2016;152(7):768-775. https://pubmed.ncbi.nlm.nih.gov/27050279
- Lee S, Lee YB, Choe SJ, Lee WS. Adverse sexual effects of treatment with finasteride or dutasteride for male androgenetic alopecia: a systematic review and meta-analysis. Acta Derm Venereol. 2019;99(1):12-17. https://pubmed.ncbi.nlm.nih.gov/30206635
- Mella JM, Perret MC, Manzotti M, Catalano HN, Guyatt G. Efficacy and safety of finasteride therapy for androgenetic alopecia: a systematic review. Arch Dermatol. 2010;146(10):1141-1150. https://pubmed.ncbi.nlm.nih.gov/20956649
- Yuan J, Zhang R, Yang Z, et al. Comparative effectiveness and safety of oral phosphodiesterase type 5 inhibitors for erectile dysfunction: a systematic review and network meta-analysis. Eur Urol. 2013;63(5):902-912. https://pubmed.ncbi.nlm.nih.gov/23395275
- Zhao B, Hong Z, Wei Y, Yu D, Xu J, Zhang W. Erectile dysfunction predicts cardiovascular events as an independent risk factor: a systematic review and meta-analysis. J Sex Med. 2019;16(7):1005-1017. https://pubmed.ncbi.nlm.nih.gov/31104857
- Burnett AL, Nehra A, Breau RH, et al. Erectile dysfunction: AUA guideline. J Urol. 2018;200(3):633-641. https://pubmed.ncbi.nlm.nih.gov/29746858
- U.S. Food and Drug Administration. FDA warns consumers about compounded versions of semaglutide and other GLP-1 receptor agonists. 2023. https://www.fda.gov/drugs/human-drug-compounding/fdas-concerns-about-compounded-versions-semaglutide
- Vittone J, Blackman MR, Busby-Whitehead J, et al. Effects of single nightly injections of growth hormone-releasing hormone (GHRH 1-29) in healthy elderly men. Metabolism. 1997;46(1):89-96. https://pubmed.ncbi.nlm.nih.gov/9005976
- Molitch ME, Clemmons DR, Malozowski S, Merriam GR, Vance ML. Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(6):1587-1609. https://pubmed.ncbi.nlm.nih.gov/21602453
- Murphy N, Knuppel A, Papadimitriou N, et al. Insulin-like growth factor-1, insulin-like growth factor-binding protein-3, and breast cancer risk: observational and Mendelian randomization analyses. Lancet Diabetes Endocrinol. 2020;8(4):356-366. https://pubmed.ncbi.nlm.nih.gov/32105579
- American Telemedicine Association. Practice guidelines for telehealth. 2020. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7577680